Press Releases
April 2021
March 2021
25.03.2021 MECOTEC Group from Germany delivers High-Tech Container MCF-8 for the transport and safe deep freeze cold storage at -20°C (-4°F) to - 80°C (-112°F) for Covid-19 Vaccines to the Philippines
Presentation of the first mobile hybrid container MCF-8 in the presence of the Minister for Economics, Science and Digitization of the State of Saxony-Anhalt, Prof. Dr. Armin Willingmann, and the Deputy Ambassador Chief of Mission Ms. Lillibeth V. Pono of the Philippines in Germany read more tweet Print15.03.2021 IDT Biologika and Takeda support production of the Johnson & Johnson single-shot COVID-19 vaccine
IDT Biologika is now using capacities at its Dessau site previously reserved for Takeda Pharmaceutical Company’s dengue vaccine candidate to fill and package the single-shot COVID-19 vaccine developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. IDT and Takeda announced an agreement to this end today. The vaccine is manufactured in Dessau for worldwide distribution. read more tweet Print08.03.2021 New inhibitor found to combat drug-resistant cancer cells
A new substance could improve the treatment of persistent cancers. Researchers at Martin Luther University Halle-Wittenberg (MLU) and the University of Greifswald have developed a new inhibitor that makes drug-resistant tumour cells respond again to chemotherapy. The new substance blocks a protein in the cancer cells that normally transports the cancer drugs back out of the cells. The results were published in the scientific journal "Molecules". read more tweet PrintFebruary 2021
22.02.2021 Capital increase at ThermHex
ThermHex Waben GmbH increases its capital to 1 million euros. The shareholders’ meeting of the parent company EconCore NV had already approved this in 2020. The increase of 900,000 euros has now been entered in the commercial register before the end of the financial year. With the very successful financial year and the capital increase, ThermHex is strengthening its position in the market. read more tweet Print10.02.2021 IDT Biologika and AstraZeneca establish strategic partnership for vaccine production
Vaccine manufacturer IDT Biologika will jointly invest in additional production capacities at its headquarters in Dessau with pharmaceutical group AstraZeneca. The two companies signed an agreement to this effect last Friday. Details of the cooperation will be determined in the coming weeks. read more tweet Print
